Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
[Live-combined Bifidobacterium, Lactobacillus, and Enterococcus improves heat tolerance and attenuates systemic inflammatory injury in heat-stroke rats via modulation of gut microbiota and intestinal barrier].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xie Jiangbo, Xue Zhengbiao, Ding Shuchang, Wen Peishan, Wen Yanhua
Аннотация
OBJECTIVES: To investigate the ameliorative effects of live combined Bifidobacterium, Lactobacillus and Enterococcus (LCBLE) preparation on heat tolerance and systemic inflammatory injury in rats with heat stroke, and to explore its underlying mechanisms.
METHODS: Rats were randomly divided into blank control, LCBLE control, model control, and LCBLE treatment groups. Rats in the LCBLE control and LCBLE treatment groups were administered LCBLE by gavage for 7 consecutive days prior to heat stroke modeling, while those in the blank control and model control groups received an equal volume of physiological saline. On day 8, heat stroke was induced in the model control and LCBLE treatment groups. Core body temperature, body weight and survival rate were monitored. Serum levels of inflammatory factors and intestinal fatty acid-binding protein (I-FABP) were measured by enzyme-linked immunosorbent assay; D-lactate levels were detected by lactate colorimetry; endotoxin levels were measured by limulus amebocyte lysate test; histopathological morphology of intestinal tissues was observed by hematoxylin-eosin staining and scored; tight junction proteins and E-cadherin in colonic tissues were localized by immunofluorescence staining; colonic epithelial ultrastructure was observed by transmission electron microscope; and the composition and structural characteristics of the intestinal flora were analyzed by 16S rRNA sequencing.
RESULTS: Compared with the model control group, LCBLE treatment significantly reduced peak core body temperature [(43.21±0.33) ℃ vs. (42.03±0.43) ℃, P<0.01], attenuated weight loss [(286.68±12.61) g vs. (307.76±11.29) g, P<0.05 ], and improved survival rate (55.6% vs. 77.8%, P<0.05). Furthermore, serum levels of tumor necrosis factor-α, IL-6, and IL-1β were significantly reduced in the LCBLE treatment group (all P<0.01); indicators of intestinal barrier dysfunction, including D-lactate, I-FABP, and endotoxin, were also significantly decreased (all P<0.05); histopathological injury in various intestinal segments was alleviated, with reduced injury scores (all P<0.01), and the expression of tight junction proteins (zonula occludens protein 1, occludin), and E-cadherin as well as the ultrastructural integrity of colonic epithelium were restored. 16S rRNA sequencing revealed that LCBLE significantly increased the relative abundances of Bifidobacterium and Lactobacillus in the gut.
CONCLUSIONS: Prophylactic administration of LCBLE improves heat tolerance and alleviates systemic inflammatory injury in heat stroke rats, likely through maintaining intestinal barrier integrity and regulating gut microbiota.
METHODS: Rats were randomly divided into blank control, LCBLE control, model control, and LCBLE treatment groups. Rats in the LCBLE control and LCBLE treatment groups were administered LCBLE by gavage for 7 consecutive days prior to heat stroke modeling, while those in the blank control and model control groups received an equal volume of physiological saline. On day 8, heat stroke was induced in the model control and LCBLE treatment groups. Core body temperature, body weight and survival rate were monitored. Serum levels of inflammatory factors and intestinal fatty acid-binding protein (I-FABP) were measured by enzyme-linked immunosorbent assay; D-lactate levels were detected by lactate colorimetry; endotoxin levels were measured by limulus amebocyte lysate test; histopathological morphology of intestinal tissues was observed by hematoxylin-eosin staining and scored; tight junction proteins and E-cadherin in colonic tissues were localized by immunofluorescence staining; colonic epithelial ultrastructure was observed by transmission electron microscope; and the composition and structural characteristics of the intestinal flora were analyzed by 16S rRNA sequencing.
RESULTS: Compared with the model control group, LCBLE treatment significantly reduced peak core body temperature [(43.21±0.33) ℃ vs. (42.03±0.43) ℃, P<0.01], attenuated weight loss [(286.68±12.61) g vs. (307.76±11.29) g, P<0.05 ], and improved survival rate (55.6% vs. 77.8%, P<0.05). Furthermore, serum levels of tumor necrosis factor-α, IL-6, and IL-1β were significantly reduced in the LCBLE treatment group (all P<0.01); indicators of intestinal barrier dysfunction, including D-lactate, I-FABP, and endotoxin, were also significantly decreased (all P<0.05); histopathological injury in various intestinal segments was alleviated, with reduced injury scores (all P<0.01), and the expression of tight junction proteins (zonula occludens protein 1, occludin), and E-cadherin as well as the ultrastructural integrity of colonic epithelium were restored. 16S rRNA sequencing revealed that LCBLE significantly increased the relative abundances of Bifidobacterium and Lactobacillus in the gut.
CONCLUSIONS: Prophylactic administration of LCBLE improves heat tolerance and alleviates systemic inflammatory injury in heat stroke rats, likely through maintaining intestinal barrier integrity and regulating gut microbiota.